|
Business Strategy
Our goal is to expand our existing leadership in the growing field of regenerative medicine.
This is being achieved today via aggressive development of our unique skill set to take complex, living therapies from research and development, through manufacturing, to successful commercialization.
Specifically,
- Research and Development:
- Aggressive development of our VCT de novo human collagen technology platform
- Multiple clinical trials currently underway in multiple therapeutic areas
- Strong & deep collaborations with academia
- Manufacturing:
- Pioneer automated cell therapy production
- Decrease costs via scale and product synergy
- Ship living technology, in a controlled environment, reliably around the world
- Commercialization:
- Promoting practical, evidence based products for wide use in the medical community.
- Continued commitment to our best-in-class "Regenerative Medicine Specialist" sales team
Our company’s "raison d' ętre" is to develop and constantly refine the specific skill sets that are required to bring living regenerative medicine products to market and to change the lives of the patients who rely upon our therapies. A measure of true success is when the medical marvel of regenerative medicine reaches the millions of patients who can benefit from this exciting medical innovation. |
 |
